Evidence map›Paper›PMID 34789979›Full record

ArticleJournal of parasitic diseases : official organ of the Indian Society for Parasitology2021

In vitro effect of artemether-loaded nanostructured lipid carrier (NLC) on

Meisam Khazaei, Vahid Rahnama, Mohammad Hossein Motazedian, Soliman Mohammadi Samani, Gholamreza Hatam

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of parasitic diseases : official organ of the Indian Society for Parasitology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Investigation of antileishmanial activities of CaO nanoparticles onJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2023
    Article
  5. Cytotoxic screening and in vitro effect of sodium chlorite againstJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Article
  6. Challenges and Tools for In VitroPathogens (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Meisam KhazaeiDepartment of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Vahid RahnamaDepartment of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohammad Hossein MotazedianDepartment of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID 0000-0003-0117-9666
Soliman Mohammadi SamaniDepartment of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Gholamreza HatamDepartment of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Shiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Visceral leishmaniasis (VL) is an acute and deadly form of leishmaniasis, caused by

Indexed as

ArtemetherDrug deliveryLeishmania infantumMTT assayNanostructured lipid carrier (NLC)

Identifiers

PMID34789979
PMCPMC8556446
OpenAlexW3153777600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.